New stem cells drive regenerative medicine research

The impulse of regenerative medicine

Scientists and researchers at the University of Hong Kong (China) have created Expanded Potential Stem Cells (EPSC) from human cells and pigs. These stem cells have the characteristics of the first cells in the developing embryo and can develop into any type of cell. Certainly, these new stem cells drive regenerative medicine research.

These cells have incredible potential for studying human development and regenerative medicine.

A great study

Certainly, this study is the first in which scientists have been able to obtain embryonic stem cells from primitive pigs. It is due to the domestic pigs have great potential for biomedical research. They have genetic and anatomical similarities to humans. In addition, being able to genetically modify pig stem cells will also benefit animal health and food production.

Fortunately, stem cells have the ability to develop into other cell types. The types of stem cell lines currently available have limitations. So far, it has not been possible to create embryonic stem cells from pigs and many other farm animals either.

During the last years, scientists have been trying to derive porcine embryonic stem cells without much success. For this reason, this study represents a significant advance in stem cell research.

The first EPSCs were created in 2017. In these early stages of embryonic development, the mammalian species are very similar.

This show that it is possible to use the same approach to create human EPSC and also to establish EPSC from pigs.

New opportunities for pregnancy complications

Researchers have explained that these cells offer new opportunities to investigate pregnancy complications, such as pre-eclampsia and miscarriages.

Dr. Xuefei Gao has pointed out that these EPSC stem cells “will allow researchers to study early embryonic development, miscarriage, and developmental disorders.

Monika Nowak-Imialek, doctor and editor of the German newspaper Friedrich-Loeffler-Institut (FLI), said that “the great potential for the development of EPSC in any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and drug detection”.

Hong Kong has had the potential and the capacity to create new stem cells drive regenerative medicine research. It will have a great impact on the world.

Finally, we recommend you to go to Japan and try to collaborate with the investigations. Do not forget to buy a hong kong pre arrival registration to enter the country.